Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EBT (2016 - 2023)

Historic EBT for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to -$14.1 million.

  • Cellectis' EBT rose 3954.64% to -$14.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$40.4 million, marking a year-over-year increase of 4435.07%. This contributed to the annual value of -$80.8 million for FY2022, which is 13379.63% down from last year.
  • As of Q3 2023, Cellectis' EBT stood at -$14.1 million, which was up 3954.64% from $3.1 million recorded in Q2 2023.
  • Over the past 5 years, Cellectis' EBT peaked at $14.4 million during Q1 2020, and registered a low of -$42.4 million during Q3 2021.
  • For the 5-year period, Cellectis' EBT averaged around -$22.3 million, with its median value being -$23.4 million (2022).
  • As far as peak fluctuations go, Cellectis' EBT soared by 16233.83% in 2020, and later plummeted by 23812.79% in 2021.
  • Quarter analysis of 5 years shows Cellectis' EBT stood at -$38.5 million in 2019, then decreased by 1.74% to -$39.2 million in 2020, then skyrocketed by 79.39% to -$8.1 million in 2021, then plummeted by 47.88% to -$11.9 million in 2022, then decreased by 18.34% to -$14.1 million in 2023.
  • Its EBT stands at -$14.1 million for Q3 2023, versus $3.1 million for Q2 2023 and -$17.5 million for Q1 2023.